# Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty

> **NCT07634523** · PHASE4 · RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Sarcopenia
- Total Knee Arthroplasty

## Interventions

- **DRUG:** Livact Granule

## Key facts

- **NCT ID:** NCT07634523
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-06
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634523, "Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07634523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*